India’s national drug regulation organisation has recently approved 2 vaccines for emergency use, one of which is yet to make it through phase III clinical trial. The national approval of Covaxin, developed in India by […]
The higher than usual rate of allergic reactions caused by the novel Covid-19 vaccine developed by Pfizer/BioNTech is thought to be due to a chemical compound in the packaging called polyethylene glycol (PEG). The PEG […]
The CEO of Qantas, Alan Joyce, has stated that a Covid-19 vaccination will be required for all international passengers when the vaccine is available. “We will ask people to have a vaccination before they can […]
Pfizer and BioNTech are determined to release their Covid-19 vaccine as soon as possible, setting the optimistic benchmark of December 2020. “There is a chance that we can receive approval from the US or Europe […]
In the global race to develop the most effective Covid-19 vaccine, Pfizer and BioNTech are determined to establish their position as top candidate. Phase 3 results involving 43,000 participants have concluded that the Pfizer and […]
The required frozen transport of upcoming Covid-19 vaccines, developed by Pfizer/BioNTech and Moderna, are posing a problem for effective distribution. Pfizer have stated that their vaccine requires storage and transportation at -70 degrees celsius. Below […]
Copyright © 2022 | MH Magazine WordPress Theme by MH Themes